Insider Buying: Diaceutics PLC (LON:DXRX) Insider Acquires 126 Shares of Stock

Diaceutics PLC (LON:DXRX - Get Free Report) insider Nick Roberts bought 126 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average price of GBX 119 ($1.58) per share, for a total transaction of £149.94 ($198.96).

Diaceutics Stock Performance

Diaceutics stock traded down GBX 0.90 ($0.01) during mid-day trading on Friday, reaching GBX 121.10 ($1.61). The company's stock had a trading volume of 38,584 shares, compared to its average volume of 98,719. The firm's fifty day moving average price is GBX 123.41 and its two-hundred day moving average price is GBX 127.34. Diaceutics PLC has a 12-month low of GBX 95 ($1.26) and a 12-month high of GBX 151 ($2.00). The company has a market capitalization of £102.20 million, a P/E ratio of -35.92 and a beta of 0.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.